Literature DB >> 30810336

Idiopathic Pulmonary Fibrosis Guideline Recommendations. Need for Adherence to Institute of Medicine Methodology?

Kevin C Wilson1, Noah C Schoenberg1, Ganesh Raghu2.   

Abstract

Rationale: The 2018 idiopathic pulmonary fibrosis (IPF) guidelines were developed using an approach that adhered to the Institute of Medicine (IOM) standards, in which each recommendation was informed by a systematic review. The convergence of opinion on recommendations and evidence (CORE) process is a modified Delphi process that does not require a systematic review but yields similar recommendations.
Objectives: To determine the importance of systematic reviews to the recommendations made by the IPF guidelines.
Methods: IPF experts who were not on the IPF guideline panel and had no knowledge of the guideline's evidence synthesis or recommendations were recruited to answer the same questions as the guidelines but using a modified CORE process. Recommendations derived from the modified CORE process and IOM-adherent process were then compared. Concordance of the course of action, strength of recommendation, and quality of evidence was measured.
Results: Ten questions were addressed. The modified CORE process and IOM-adherent process yielded concordant recommendations for 9 of 10 (90%) questions (ĸ-agreement, 0.84; 95% confidence interval, 0.55-1.00). The strength of the recommendations was the same for seven of eight (88%) graded recommendations (ĸ-agreement, 0.75; 95% confidence interval, 0.31-1.00), but ratings of the quality of evidence were discordant. The modified CORE process was less expensive and required less time and effort than the IOM-adherent process. Conclusions: The modified CORE process developed recommendations that were concordant with those developed by an experienced guideline panel using the robust standards of the IOM; however, it was less expensive and less burdensome.

Entities:  

Keywords:  clinical practice guidelines; idiopathic pulmonary fibrosis; interstitial lung disease

Mesh:

Year:  2019        PMID: 30810336     DOI: 10.1513/AnnalsATS.201812-871OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  6 in total

Review 1.  Update in Interstitial Lung Disease 2019.

Authors:  Sydney B Montesi; Jolene H Fisher; Fernando J Martinez; Moisés Selman; Annie Pardo; Kerri A Johannson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-15       Impact factor: 21.405

2.  Community-acquired Pneumonia Guideline Recommendations-Impact of a Consensus-based Process versus Systematic Reviews.

Authors:  Kevin C Wilson; Noah C Schoenberg; David L Cohn; Kristina Crothers; Kevin P Fennelly; Joshua P Metlay; Jussi J Saukkonen; Charlie Strange; Grant Waterer; Raed Dweik
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

3.  COVID-19: guidance on palliative care from a European Respiratory Society international task force.

Authors:  Daisy J A Janssen; Magnus Ekström; David C Currow; Miriam J Johnson; Matthew Maddocks; Anita K Simonds; Thomy Tonia; Kristoffer Marsaa
Journal:  Eur Respir J       Date:  2020-09-03       Impact factor: 16.671

4.  Quality of evidence supporting Surviving Sepsis Campaign Recommendations.

Authors:  Jordi Rello; Sofia Tejada; Elena Xu; Candela Solé-Lleonart; Laura Campogiani; Despoina Koulenti; João Ferreira-Coimbra; Jeff Lipman
Journal:  Anaesth Crit Care Pain Med       Date:  2020-07-07       Impact factor: 4.132

5.  The 2018 Diagnosis of Idiopathic Pulmonary Fibrosis Guidelines: Surgical Lung Biopsy for Radiological Pattern of Probable Usual Interstitial Pneumonia Is Not Mandatory.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Jeffrey Myers; Luca Richeldi; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2019-11-01       Impact factor: 21.405

Review 6.  Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020).

Authors:  Chunxue Bai; Sanjay H Chotirmall; Jordi Rello; George A Alba; Leo C Ginns; Jerry A Krishnan; Robert Rogers; Elisabeth Bendstrup; Pierre-Regis Burgel; James D Chalmers; Abigail Chua; Kristina A Crothers; Abhijit Duggal; Yeon Wook Kim; John G Laffey; Carlos M Luna; Michael S Niederman; Ganesh Raghu; Julio A Ramirez; Jordi Riera; Oriol Roca; Maximiliano Tamae-Kakazu; Antoni Torres; Richard R Watkins; Miriam Barrecheguren; Mirko Belliato; Hassan A Chami; Rongchang Chen; Gustavo A Cortes-Puentes; Charles Delacruz; Margaret M Hayes; Leo M A Heunks; Steven R Holets; Catherine L Hough; Sugeet Jagpal; Kyeongman Jeon; Takeshi Johkoh; May M Lee; Janice Liebler; Gerry N McElvaney; Ari Moskowitz; Richard A Oeckler; Iñigo Ojanguren; Anthony O'Regan; Mathias W Pletz; Chin Kook Rhee; Marcus J Schultz; Enrico Storti; Charlie Strange; Carey C Thomson; Francesca J Torriani; Xun Wang; Wim Wuyts; Tao Xu; Dawei Yang; Ziqiang Zhang; Kevin C Wilson
Journal:  Eur Respir Rev       Date:  2020-10-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.